Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

Total article views   HTML views PDF downloads Totals
9,311 Dovepress* 6,524+ 388 6,912
PubMed Central* 2,787 435 3,222
Totals 9,311 823 10,134
*Since 13 April 2022

View citations on PubMed Central and Google Scholar